OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply
Lauren A. McIntosh, Jonathan D. Burns, E. E. Tereshatov, et al.
Nuclear Medicine and Biology (2023) Vol. 126-127, pp. 108387-108387
Open Access | Times Cited: 11

Showing 11 citing articles:

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
Suzanne E. Lapi, Peter J. H. Scott, Andrew M. Scott, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 6, pp. e236-e249
Closed Access | Times Cited: 13

Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics
Masayuki Munekane, Takeshi Fuchigami, Kazuma Ogawa
Analytical Sciences (2024) Vol. 40, Iss. 5, pp. 803-826
Open Access | Times Cited: 6

Probing the Redox Reactivity of Alkyl Bound Astatine: A Study on the Formation and Cleavage of a Stable At–C Bond
Jehan S. Perera, Jennifer M. Pyles, Avinash K. Srivastava, et al.
Inorganic Chemistry (2025) Vol. 64, Iss. 2, pp. 911-921
Closed Access

Compact automated apparatus for rapid astatine recovery from nitric acid media: Design, application, and impurity characterization
E. E. Tereshatov, Jonathan D. Burns, Steven J. Schultz, et al.
Chemical Engineering Journal (2022) Vol. 442, pp. 136176-136176
Open Access | Times Cited: 12

Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer
Tadashi Watabe, Kazuko Kaneda‐Nakashima, Yuichiro Kadonaga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5667-5667
Open Access | Times Cited: 2

Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Jun Toyohara, Daniëlle J. Vugts, Oliver C. Kiss, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Production, purification and formulation of Nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy
Sanchita Ghosh, Debashis Banerjee, Apurav Guleria, et al.
Nuclear Medicine and Biology (2024) Vol. 138-139, pp. 108947-108947
Closed Access | Times Cited: 1

Optimised solid-phase extraction of 211At: activity balance of 211At, 210At and 210Po after wet chemistry target dissolution
Matthijs B. Sevenois, Holger Jan Jensen, Férid Haddad, et al.
Radiation Physics and Chemistry (2024) Vol. 225, pp. 112146-112146
Open Access | Times Cited: 1

Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy
Marianna Tosato, Chiara Favaretto, Janke Kleynhans, et al.
Nuclear Medicine and Biology (2024) Vol. 142-143, pp. 108990-108990
Open Access | Times Cited: 1

The future of the radiopharmaceutical sciences
Suzanne E. Lapi, Peter J. H. Scott
Nuclear Medicine and Biology (2024) Vol. 132-133, pp. 108907-108907
Closed Access

Page 1

Scroll to top